March 2026
The global kidney cancer drugs market size is calculated at USD 7.24 billion in 2025 and is projected to hit around USD 12.16 billion by 2035 with a CAGR of 5.32%.
September 2026
The global head and neck cancer drugs market size surpassed USD 20.09 billion in 2026 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
September 2026
The oncology/cancer drugs market size is calculated at USD 214.70 billion in 2026 and is projected to hit around USD 554.69 billion by 2035 with a CAGR of 11.17%.
September 2026
The ovarian cancer drugs market reached USD 4.36 billion in 2026, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
September 2026
The AI in cancer immunotherapy drugs market reached USD 3.52 billion in 2026, featuring leading AI in cancer immunotherapy drugs market companies such as Exscientia, Insilico Medicine.
December 2025
The global cancer supportive care drugs market size is projected to hit around USD 27.45 billion by 2035 from USD 22.31 billion in 2025 with a CAGR of 2.09%.
September 2026
The global PD-1 inhibitor drugs market size was estimated at USD 56.29 billion in 2026 and is expected to hit around USD 201.87 billion by 2035, growing at a CAGR of 15.28% from 2026 to 2035.
September 2026
The global erectile dysfunction drugs market size was estimated at USD 2.93 billion in 2024 and is predicted to be worth around USD 6.74 billion by 2034, with a CAGR of 8.69%.
September 2026
The global epigenetics drugs and diagnostic technologies market size is estimated to hit around USD 79.03 billion by 2035 increasing from USD 23.13 billion in 2026, with a CAGR of 14.63%.
September 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global pingueculum drugs market size was evaluated at USD 891.64 million in 2026 and is predicted to hit around USD 1,660.04 million by 2035, growing at a CAGR of 7.15%.
September 2026
The global sedative-hypnotic drugs market size was evaluated at USD 16.80 billion in 2026 and is predicted to hit around USD 31.94 billion by 2035, growing at a CAGR of 7.40%.
September 2026
The global antiepileptic drugs market size was evaluated at USD 19.02 billion in 2026 and is predicted to hit around USD 30.80 billion by 2035, growing at a CAGR of 5.50%.
September 2026
The global synthetic lethality-based drugs and targets market size was evaluated at USD 2.19 billion in 2026 and is predicted to hit around USD 9.37 billion by 2035, growing at a CAGR of 17.52%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
September 2026
The contraceptive drugs market size reached USD 20.12 billion in 2026, with leading contraceptive drugs market companies including Pfizer Inc., Bayer AG, Merck and Co. Inc.
September 2026
The rheumatoid arthritis drugs market size reached USD 65.51 billion in 2026, with leading rheumatoid arthritis drugs market companies including AbbVie Inc., Sun Pharma, Lupin.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The neoantigen cancer vaccine market was worth USD 551.46 million in 2026, with key neoantigen cancer vaccine market players including Moderna Inc, BioNTech SE.
September 2026
The global cardiovascular drugs market size is valued at USD 162.02 billion in 2026 and is expected to hit around USD 221.20 billion by 2035, growing at a CAGR of 3.56% from 2026 to 2035.
September 2026
The global cancer therapeutics market size was evaluated at USD 232.14 billion in 2026 and is expected to surpass around USD 501.07 billion by 2035 with a CAGR of 8.95%.
September 2026
The global cancer registry software market size is expected to increase from USD 106.52 million in 2026 to hit around USD 301.40 million by 2035, with a CAGR of 12.28%.
September 2026
The global cancer biomarkers market size was estimated at USD 17.49 billion in 2026 and is projected to hit around USD 47.14 billion by 2035 with a CAGR of 11.71%.
September 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 20.28 billion in 2026, with a CAGR of 9.25%.
September 2026
The cervical cancer diagnostic market size accounted for USD 10.33 billion in 2026 and is expected to hit around USD 16.04 billion by 2035 with a CAGR of 5.03%.
September 2026
The global cancer vaccine market size was calculated at USD 11.32 billion in 2024 and is projected to hit around USD 33.38 billion by 2034 with a soild CAGR of 11.42%.
September 2026
The global stomach cancer treatment market size is estimated to surpass around USD 19.42 billion by 2035 from USD 6.84 billion in 2026, with a solid CAGR of 12.31%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com